Affiliation:
1. Samara State Medical University
2. Samara Regional Clinical Hospital named after V.D. Seredavin
Abstract
The article presents data on the clinical and pathogenetic variants of fetal growth restriction (FGR). FGR is one of the typical clinical manifestations of large obstetric syndromes, is associated with a high perinatal morbidity and has a significant impact on the quality and duration of human life. The emphasis is made on the differences in pathogenesis, the features of prediction, diagnosis, obstetric management and the assessment of perinatal outcomes in the early and late phenotype of the FGR. The review includes materials from domestic and foreign scientific literature that found in eLibrary and PubMed on this topic and published for the last 10 years. This article discusses the role of the formation of the embryo(feto)placental system under the influence of existing periconceptional risk factors in the implementation of various phenotypes of FGR. An analysis of the literature shows that the fetal growth potential, which genetically and epigenetically determined, changes during pregnancydepending on maternal, placental and fetal factors, which ultimately determine the final weight-growth parameters of the newborn. The issues of informativeness of clinical, laboratory and instrumental predictors, diagnostic criteria, the choice of rational obstetric management in case of FGR of various periods of manifestation are discussed in this article. Convincing data on the perinatal and long-term consequences of intrauterine growth restriction are presented. The pathogenetic variant of FGR determines the features of the functioning of the immune system, has a significant impact on the programming of metabolic and endocrine processes, the formation of fetal brain structures. Identification of pregnant women at risk for the development of FGR of various periods of manifestation, timely diagnosis, selection of the timing and method of delivery should correspond to the main directions of the "4P-model" of modern medicine and represent an integral predictive, preventive and personalized system of examination and observation based on evidence-based medicine data and the requirements of practical obstetrics and perinatology.
Reference48 articles.
1. Zhang S., Hu Z., Tanji H., Jiang S., Das N., Li J. et aL. SmaLL-moLecuLe inhibition of TLR8 through stabiLization of its resting state. Nat Chem Biol. 2018;14(1):58-64. doi: 10.1038/nchembio.2518.
2. AyLamazyan E.K., Serov V.N., Radzinsky V.E., SaveLeva G.M. (eds.) Obstetrics. National guide. Moscow: GEOTAR-Media; 2015. 1080 р. (In Russ.) AvaiLabLe at: https://www.rosmedLib.ru/book/ISBN9785970432150.htmL.
3. Voskamp BJ., Kazemier B.M., RaveLLi A.C., Schaaf J., MoL B.W., Pajkrt E. Recurrence of smaLL for gestationaL age pregnancy: anaLysis of first and subsequent singLeton pregnancies in the NetherLands. Am J Obstet Gynecol. 2013;208(5):374.e1-6. doi: 10.1016/j.ajog.2013.01.045.
4. ShabaLov N.R DeLay of intrauterine growth and deveLopment. In: Neonatology. 5th ed. Moscow: MEDpress-inform; 2009. VoL. 1, pp. 113-138. (In Russ.) AvaiLabLe at: https://Library.sammi.uz/Library/%D0%A0%D1%83%D1%81%D1%81%D0%BA%D0%B8%D0%B9/%D0%9D%D0%B5%D0%BE%D0%BD%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/%D0%9D%D0%B5%D0%BE%D0%BD%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F%20%D0%A8%D0%B0%D0%B1%D0%B0%D0%BB%D0%BE%D0%B2%201%20%D1%82.pdf.
5. Guiducci C., Gong M., Cepika A.M., Xu Z., Tripodo C., Bennett L. et aL. RNA recognition by human TLR8 can Lead to autoimmune infLammation. J Exp Med. 2013;210(13):2903-2919. doi: 10.1084/jem.20131044.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献